S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NEO NeoGenomics Inc

12.63

0.00 (0.00%)

Pre Market

Last Updated: 06:08:49

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

NeoGenomics (NASDAQ:NEO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more NeoGenomics Charts.

NeoGenomics (NASDAQ:NEO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more NeoGenomics Charts.

NeoGenomics Inc News

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
Tuesday 14 January 2025 (9 minutes ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 10 January 2025 (4 days ago) • Edgar (US Regulatory)

NeoGenomics Announces Chief Executive Officer Succession
Friday 10 January 2025 (4 days ago) • Business Wire

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Monday 6 January 2025 (1 week ago) • Business Wire

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
Wednesday 11 December 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 December 2024 (1 month ago) • Edgar (US Regulatory)

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
Monday 9 December 2024 (1 month ago) • Business Wire

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 4 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Tuesday 19 November 2024 (2 months ago) • Business Wire

Form 144 - Report of proposed sale of securities
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

More NeoGenomics Inc News Articles

Code Green Apparel (PK)

UAV Corpoation (PK)

Saddle Ranch Media (PK)

Digital Brand Media and ... (PK)

FuelCell Energy

Liquidmetal Technologies (QB)

Anavex Life Sciences

Tonix Pharmaceuticals

Moon Equity (PK)

Bioelectronics (PK)

North Bay Resources (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions